×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
IMPLEMENTATION OF THE NEW PHARMACOVIGILANCE LEGISLATION
Session Chair(s)
Vicki Edwards, RPh
Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom
Update from the Generic Pharma Industry
Learning Objective : You will be able to get an overview of the impact and difficulties of PASS for generic companies since the implementation of the new pharmacovigilance legislation.
Speaker(s)
A regulator’s view of the early impllematation of the the new PV legislation
Mick Foy
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Director of Delivery
Update from the Innovative Pharma Industry
Laurent Auclert, MD
France
Pharmacovigilance Expert
Update from the Generic Pharma Industry
Maarten Van Baelen, MBA, MPharm
Medicines for Europe, Belgium
Market Access Director
Have an account?